Murugan Pandian


Adjunct Professor, Medicine
School of Medicine

Ph.D., All India Institute of Medical Sciences,New Delhi , India, 1973, Endocrinology/Immunology

Phone: (714) 456-8338
Email: mpandian@uci.edu

University of California, Irvine
Nephrolgy
Irvine, CA 92697
Research Interests
In Vitro Diagnostic tests development
URL
Academic Distinctions
Sakuntala Amirchand Prize for the Year 1972 by the Indian Council of Medical Research for outstanding contribution of "Growth Hormone Vis-A-Vis Thymus Metabolism and Immune Response Against Sheep Erythrocytes".
Appointments
Research Associate under Professor O. P. Bahl, Chairman, Department of Biological Sciences, State University of New York, Buffalo, New York (Jun. 1974 to Oct. 1977)
Research Abstract
Pandian M.R., Anand Kumar T.C., and Talwar G.P. (1969) Studies on the hormonal control of lipogenesis in adipose tissue in vitro. Symp. on "Lipids", New Delhi Abstract No. 21.
2. Pandian M.R. and Talwar G.P. (1970) Effect of growth hormones on the synthesis of nucleic acids in the lymphoid organs and on immune response of the animals to sheep erythrocytes. Convention of Chemists, Madras, India, Abstract No. B-16-70.
3. Pandian M.R. and Talwar G.P. (1971) Evidence of the action of growth hormone on the membranes of thymocytes. 41st Annual Meeting of the Society of Biological Chemists. Pant Nagar, India, Abstract No. H11.
4. Pandian M.R. and Bahl O.P. (1975) Labeling of LH/hCG receptors. Fed. Proc. 34, 584.
5. Pandian M.R. and Bahl O.P. (1975) Specific labeling of LH/hCG receptors with 131I. 57th Annual Meeting of the Endocrine Society, Abstract No. 173.
6. Pandian M.R., Ghai R.D., Carlsen R.B., and Bahl O.P. (1976) Immunological and receptor binding activity of human chorionic gonadotropin and its derivatives. Fed. Proc. 35, 1719.
7. Gupta S.R., Pandian M.R., and Bahl O.P., (1976) Incorporation of LH/hCG receptor into rat thymocytes. 58th Annual Meeting of the Endocrine Society, Abstract No. 256.
8. Bahl O.P., Ghai R.D., and Pandian M.R. (1977) Immunological properties of the ? subunit of hCG: Development of a specific antigen for contraception. 59th Annual Meeting of the Endocrine Society, Abstract No. 118.
9. Pandian M.R. and Bahl O.P. (1977) Immunological properties of the ? subunit of hCG: Preparation of specific antibodies and their properties. 59th Annual Meeting of the Endocrine Society, Abstract No. 120.
10. Pandian M.R., Said S.I., and Broughton A. (1982) Radioimmunoassay from vasoactive intestinal polypeptide (VIP). Clin. Chem. 28:1597.
11. Beard M., Pandian M.R., Henninger R. and Broughton A. (1982) Development of a radioimmunoassay for reverse T3 and its clinical application. Clin. Chem. 28:1598.
12. Pandian M.R. and Said S.I. (1983) A simplified, improved radioimmunoassay for vasoactive intestinal polypeptide (VIP) in human plasma. Regulatory Peptide 6:321.
13. Pandian M.R., Carlton E., Valente W.A., and Fisher D.A. (1985) Application of thyroid stimulatory immunoglobulin (TSI) and thyrotopin binding inhibitory immunoglobulin (TBII) measurements in Graves Disease. 67th Annual Meeting of the Endocrine Society. Abstract No. 1359.
14. Pandian M.R., Armstrong G., Canfield R.E., and Odell W.D. (1985) Radioimmunoassay for alpha subunit of hCG, LH, FSH, and TSH using monoclonal antibody. Clin. Chem. 31: 980.
15. Vendely P., Pandian M.R., and Zack J.F. (1985) Comparison of four immunoassay methods for quantitation of carcinoembryonic antigen. Clin. Chem. 31: 981.
16. Nelson J.C., Tomei R.T., and Pandian M.R. (1985) Free T4 index results are non-specific in patients with hypothyroxenemia. International Congress of Thyroid , San Paulo, Brazil. September 1-6 Abstract No. 414.
17. Nelson J.C., Linarelli L.G., and Pandian M.R. (1986) Familial euthyroid hypothyroxinemia due to an immunoreasctive TBG lacking T4 binding activity. Clinical Research 34: 93A.
18. Nelson J.C., Tomei R., and Pandian M.R. (1986) Relationships between the mechanisms of hypothyroxinemia and mortality rates in patients with nonthyroidal illness and low serum T4 levels. Clinical Research 34: 93A.
19. Pandian M.R. and McGuire W.L. (1985) Relationship of steroid receptors and the alpha subunit in human breast tumors. Breast Cancer Research and Treatment,
6:166.
20. Elias A.N., Vaziri N.D., Pandian M.R. Iyer K. and Ansari M.A. (1986) Gamma aminobutyric acid (GABA) and the dysregulation of TSH secretion in uremia. 68th Annual Meeting of the Endocrine Society, Abst. #965.
21. Pandian M.R., La R.W., Castro L., and Fisher D.A. (1986) Radioimmunoassay for atrial natriuretic peptide (ANP) in human plasma. Clin. Chem. 32: 1071.
22. Vendely P. and Pandian M.R. (1986) Correlation of a mammary tumor associated antigen (CA 15-3) with steroid receptors in human mammary tumor extracts. Clin. Chem. 32: 1126.
23. Manoogian C., Ehrlich L., Pandian M.R., Horton R., and Fisher D.A. (1987) Atrial Natriuretic Peptide levels in patients with the syndrome of inappropriate antidiuretic hormone secretion. Western Society for Clin. Investigation. Abstract.
24. Kelly T.M., Pandian M.R., and Nelson D.H. (1987) Atrial Natriuretic Peptide levels during mineralocorticoid induced sodium retention in man. Western Society for Clin. Investigation. Abstract.
25. Kelly T.M., Pandian M.R., and Nelson D.H. (1987) Response of Atrial Natriuretic Peptide in man to sodium retention induced by mineralocoricoid. Amer. Society Clin. Investigation. Abstract.
26. Pandian M.R., Carlton E., and Fisher D. (1987) Determination of antiduretic hormone in random urine and its clinical applications. Clin. Chemistry 33:921.
27. Manoogian C., Ehrlich L., Pandian M.R., Fisher D.A., and Horton R. (1987) The role of Atrial Natriuretic Peptide in the escape phase of SIADH. Endocrine Society. Abstract #992.
28. O'Connor D.T., Pandian M.R., Cervenka J., Mezger M.S., and Parmer R.J. (1987) What is the source and disposition of Chromogranin A (CgA) in normal human Plasma? Clin. Res. 35:605A.
29. Andress D.L., Pandian M.R., Endres D.B., Sherrard D.J., and Kopp J.B. (1988) Elevated Insulin like growth factor I (IgF-I) correlated with bone formation in uremic hyperparathyroidism. American Society of Nephrology.
30. Valente W.A., Pandian M.R., and Fisher D.A. (1987) Reidel's thyroiditis: Autoantibodies which promote collagen formation. Prog. Amer. Thyroid Assoc. Meeting PPT2 (Abstr. #4)
31. Elias A.N., Domurat E.S., Pandian M.R., Fairshter R., and Kayaleh R. (1989) Plasma concentration of ANP, AVP, and hormones of renin-angiotensin system after acute exercise in physically conditioned males. The Endocrine Society. (Abstract #1132.)
32. Nelson J.C., Pandian M.R., Tomei R.T., and Fisher D.A. (1989) Relationships of TBG bound T4, prealbumin bound T4 and albumin bound T4 to TBG. Clinical Research, Carmel, CA.
33. O'Connor D.T., Pandian M.R., Cervenka J., Mezger M.S., Parmer R.J. (1989) What is the source and disposition of Chromogranin A (CgA) in normal human plasma? Clinical Reserach (ASCI), Carmel, CA.
34. Tercero J.C., Pandian M.R., and Carayon P. (1989) Development of a sensitive radiobinding assay for the measurement of autoantibodies to thyroid peroxidase in serum. Clin. Chem. 35:1208.
35. Pandian M.R., Morgan C., Nelson J.C., and Fisher D.A. (1989) A simple procedure for evaluating thyroxine binding protein abnormalities in euthyroid hyperthyroxinemia and hypothroxinemia. Clin. Chem. 35:1150.
36. Bhasin S., Swerdloff R.S., Berman N., Steiner B.S., Peterson M.A., Pandian M.R., and Galmarini M. (1989) A testosterone microcapsule formulation provides sustained androgen delivery for 10-12 weeks in hypogonadal men. Western Society of Clinical Investigation (Carmel, CA).
37. Talbot J.R., Hammond P., Farley S.M., Baylink D.J., Nelson J., Pandian M.R., and Cutler R. (1989) Intravenous but not oral 1,25 D therapy in renal failure patients increases biochemical markers of bone formation. Western Society of Clinical Investigation (Carmel, CA)
38. Bogart M.H., Pandian M.R., and Jones O.W. (1987) Screening for fetal chromosome abnormalities using maternal serum chorionic gonadotrophin levels. Society of Chromosome Res. Tokyo, Japan.

39. Wong J. and Pandian M.R. (1989) Evaluation of a sensitive immunoradiometric assay (IRMA) for ACTH. Clinical Ligand Assay Society, Philadelphia, PA.
40. Owens M.A., Beardslee A., Wenger C.R., Clark G.M., Pounds G. Oldaker T., Pandian M.R., Vendely P., and McGuire W.L. (1990). A prognostic index for patients with node positive breast cancer. 13th Annual Breast Cancer Symposium, San Antonio, TX.
41. Talbot J.R., Hammond P., Farley S.M., Baylink D.J., Nelson J. C., Pandian M.R., Taylor A.K., and Cutler R. (1990) Intravenous but not oral 1,25 D therapy increases biochemical markers of bone formation and resorption in uremic patients. American Society Bone Mineral Res.
42. Donahue L.R., Rosen C., Russell S., and Pandian M.R. (1990) Anorexia Nervosa, Hypoglycemia, and the 30K Low Molecular Weight Serum Insulin Like Growth Factor Binding Protein. Endocrine Society Meeting, Atlanta, GA Abst. #209.
43. Rein M.S., Friedman A.J., Pandian M.R. and Heffner L.J. (1990) The Secretion of IgF-I and IgF-II by Fibroid and Myometrial Explants from Women treated with a GnRh-Agonist. Endocrine Society Meeting, Atlanta, GA, Abst. #211.
44. Vendely P., Ledet S., and Pandian M.R. (1990) Evaluation of an Immunoradiometric Assay for the Quantitation of Cathepsin D in Human Breast Cancer Cytosols. Clin. Chem. 36:1070.
45. Pandian M.R., Morgan C., Carlton E., and Segre G.V. (1991) A sensitive immunoradiometric assay for PTH-RP and its clinical application in the differential diagnosis of hypercalcemia. Endocrine Society, Washington. Abstract #286.
46. Elias A.N., Gordon I., Vaziri G., Chune G, Pandian M.R., Gwinup G., and Wesley R. (1991) Portal and systemic insulin concentrations after colonic administration of insulin in intestinal enzyme protected capsule.
47. Vendely P., Vergara R., Pandian M.R. (1991) Evaluation of an immunoradiometric assay for the quantitation of a mammary tumor associated antigen (CA 549). Clin Chem. 37:1056.
48. Gailani M., Finegold D.N., Pandian M.R., Deka R., Ferrell R.E., Miric A., and Levine M.A. (1991) Restriction fragment length polymorphism (RFLP) analysis in isolated familial hypoparathyroidism. Society for Pediatric Research. Abstract #1907.
49. Johnson P.W.M., Pandian M.R., Love S., Squires L., Joel S.P., Slevin M.L. (1991) Chromogranin A: A new predictor of survival in small cell lung cancer. Amer. Soc. Clin. Oncology, Chicago.
50. Fujimura F.K., Tandon A.K., Clark G.M., Mark C., Pounds G., Vendely T., Owens M., Pandian M.R., McGUire W.L. (1991) Her 2/neu Oncogene amplification and
expression in 1103 breast tumors: correlations with other prognostic factors. Amer. Assoc. Clin. Res. #1429.
51. Elias A.N., Gordon I., Vaziri N.D., Chune G., Pandian M.R., Gwinup G.,and Wesley R. (1991) Portal and systemic insulin concentrations after colonic administration of insulin in intestinal enzyme (methyl acrylic acid copolymer) protected capsules. Amer. Assoc. Clin. Research, Seattle, WA Abstract #441.
52. Ferguson J.E., Gorman J., Bruns D.E., Pandian M.R., Bruns M.E.H. (1991) Expression of parathyroid hormone-related peptide (PTH-RP) MRNA in placental membranes and amniotic fluid (AF). Soc. Perinatal Obstetricians. Dallas, TX.
53. Elias A.N., Vaziri N.D., and Pandian M.R. (1992) Pituitary gonadal axis in experimental nephrotic syndrome in male rats. Amer. Assoc. Clin. Res. Abstract #14.
54. Kung A., Swerdloff R.S., Wang C., Berman N., Peterson M.A., Steiner B.S., Pandian M.R., Galmarini M., and Bhasin S. (1992) Pharmacokinetics of a testosterone microcapsule (TM) formulation in Los Angeles Caucasian and Hong Kong Chinese hypogonadal men. 74th Annual Endocrine Society Meeting, Abstract #373.
55. Wenger C.R., Beardslee S., Owens M.A., Pounds G., Oldaker T., Vendely P., Pandian M.R., and McGuire W.L. (1992) Flow cytometry and steroid receptors in more than 100,000 breast cancer patients. Symp. Cancer Res. San Antonio, Abstract #441.
56. Caulfield M.P., Morgan C., Carlton E., Brickman A.S., Clemens J.D., Eyre D.R., and Pandian M.R. (1993) Comparison of an immunoassay for crosslinked N-telopeptide of bone collagen with HPLC detection of pyridinolines. 75th Endocrine Society Meeting. Abstract #1044.
57. Pandian M.R., Miller L., Tercero J.C., Mertens M., Rosmalen F. and Ramakrishnan K. (1993) Comparison of four immunoassays for the quantitation of erythropoietin. Clin. Chem. 39:1274.
58. Ito R.K., Wagner S.L., Cleveland M., Morgan C.M., Provow S.A., Siegel R.S., Carlton E.I., Pandian M.R., and Bissell M.G. (1994) Development of an assay for soluble beta protein precursor and its application to aid in the diagnosis of Alzheimer's disease. Clin. Chem. 40:1026.
59. Tang J.C., Galmarini, M., Luppani C.M., Colucci M., and Pandian M.R. (1994) Development of a sensitive chemiluminescent assay for progesterone using microtiter plates. Clin. Chem. 40:1022.
60. Galmarini M., Luppani, C.M., Hochstein P., Colucci M., Pandian M.R., Tang J.C., and Horton R. (1994) Development of a chemiluminescent enzyme immunoassay for cortisol using microtiter plate. Clin. Chem. 40:1133.
61. Vendely P., Hackbart M., Azam A., and Pandian M.R. (1994) Comparison of three immunoassay methods (CA 15-3, CA 549, CA27.29) for quantitation of a breast cancer associated antigen. Clin. Chem. 40:1005.
62. Vendely P., Abukhalaf N., and Pandian M.R., (1994) Evaluation of an ultra sensitive immunochemiluminescent assay for prostate specific antigen. Clin. Chem. 40:1007.
63. Colucci M., Galmarini M., Dimayuga R., Pandian M., and Horton R. (1994) Quantification of 6 beta hydroxy cortisol in human urine by HPLC. Clin. Chem. 40:1133.
64. Serafoglon K., Pandian R., and Gertner J (1994) Urinary pyridinium crosslinks excretion in childhood is dependent on height velocity (HV). Society of Ped. Res. Meeting Abst.
65. Elias A.N., Wesley R., Gordon I.L., Pandian M.R., Vaziri N.D. Effects of adenosine infustion on renal function, plasma ANP and ADH concentrations and central hemodynamics in anesthetized pigs. Presented at the National Clinical Research Meeting, San Diego, CA, May, 1995. Clin Res.
66. Elias A.N., Stone S.C., Pandian M.R., Tayyanipour R., Rohas F.J., Swinup G. Relationship between serum esteradiol concentration and IGF-I, IGF-II and IGF-binding proteins in patients with premature ovarian failure on short-term estradiol therapy. Presented at the National Clinical Research Meeting, San Diego, CA, May, 1995. Clin Res.
67. Elias A.N., Pandian M.R., Naqvi F., Sebag J., Charles M.A., Swinup G. Relationship between prorenin, IGF-1 and IGF-binding proteins in diabetic patients. Presented at the National Clinical Research Meeting, San Diego, CA, May, 1995. Clin Res.
68. Elias A.N., Wilson A.F., Naqvi S., Pandian M.R. Effects of blood pH and blood lactate on growth hormone, prolactin, and gonadotropin release after acute exercise in male volunteers. Presented at the 77th Endocrine Soc. Annual Meeting, Washington, D.C., June, 1995; abstract #P2-140, p 325.
69. Tercero J., Vendely P., Lee J.E.S., Petersen P., Harrison H., Pandian M.R. (1999) Prorenin and direct renin as possible markers for prenatal Down syndrome detection: a pilot study. Clin. Chem. 45:A77.
70. Vendely P., Petersen P., Lee J.E.S., Tercero J., Harrison H., Pandian R. (1999) Free IGF-1 utility for prenatal Down syndrome detection: a pilot study. Clin. Chem. 45:A77.
71. Harrison H., Peterson P., Vendely P., Lee J.E.S., Tercero J., Pandian R. (1999) Evaluation of a dimeric inhibin assay for use in prenatal Down syndrome detection. Clin. Chem. 45:A77.
72. Pandian R., Lu J., and Ossolinska-Plewnia J. (2001) Clinical Application of Automated Invasive Trophoblast Antigen (ITA) asssay. Presented at the XI th Wordl Congress on Gestational Trophoblastic Diseases. Santa Fe, NM October, 2001. Abst #18.
73. Lu J., Ossolinska-Plewnia J., Hutchison S., Miller P., and Pandian R. (2001) A Direct Fully Automated assay for Invasive Trophoblast Antigen (ITA) on the Nichols Advantage Specialty System. Presented at the XI the World Congress on Gestational Trophoblastic Diseases, Santa Fe, NM; October 2001, Abstract #14.
74. Lee J.E.S., Cole L.A., Palomaki G.E., Mahoney M.J., Benn P., Vendely T., Strom C.M. and Pandian R. (2001) Maternal serum ITA utility for prenatal Down syndrome detection: A pilot study using a new automated assay. Amer J Human Genetics 69:207.
75. Strom C.M., Palomaki G.E., Knight G., Cole L.A., Mahoney J. and Pandian R. (2001) Maternal urine Invasive Trophoblastic Antigen (ITA) is a useful marker for Down Syndrome Detection in the 1st Trimester. Amer J Human Genetics 69:664.
76. Vendely P.M., Lu J., Plewnia J., Palomaki G.E., Knight G.J., Cole L.A., and Pandian M.R. (2003) Measurement of second trimester maternal serum invasive trophoblast antigen (ITA) for Down syndrome (DS) screening. Clin. Chem. 49: A132 (Suppl).
77. Carlton E., Lu J., Plewnia J.O., and Pandian M.R. (2003) Invasive trophoblast antigen (ITA): A new marker for early pregnancy detection, Down syndrome screening and trophoblastic disease diagnosis. Clin. Lig. Society Meeting, May, 2003, Abst. #4.
78. LaGrave D., Lee J.E., Strom C., and Pandian M.R. (2003) Invasive trophoblast antigen (ITA) utility for prenatal Down syndrome detection: preliminary results from a prospective study. National Society of Genetic Counselor Annual Meeting, Oct., 2003, Abst #23.
79. Sancken U, Schemer R, Pandian MR, and Lee JE (2003) Invasive trophoblast antigen ITA) as a marker of fetal aneuploidy in the first and second trimester of pregnancy. American Society of human genetics, Nov, 2003, Abstract #2492.
80. Palomaki G, Knight GJ, Neveux LM, Pandian R, and Haddow JE (2004) Maternal serum invasive trophoblast antigen (ITA) measurements in pregnancies with Trisomy 18. Amer. Soc. Hum. Gene. Oct, 2004.
81. Cook ZC, Pandian R ( 2008 ) Development and validation of a Duplex immunoassay for detection of Insulin-like growth factor-1 ( IGF-1) and IGF-1 Binding protein-3( IGFBP-3) Clin Chem 54:A121 .
82. Chandler DW , Chun KY, Pandian R , Caulfield , M , Frane J and Bright GM ( 2010 )
New IGF-1 Normative data for Healthy , contemporary US children .5 th International congress of GRS ( Growth hormone research and IGF society ) , New York ,Oct3-7 .
Abst # MS 309 .
83. Homer M, Chuan S , Pandian R , Conway D, Garzo , G and Su I ( 2012 )
Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy
Outcomes after in Vitro fertilization. Amer Soc of Reproductive Medicine,SanDiego,
CA. October 20 -24, 2012.

84. Pandian R , Pandian J and Elias A ( 2013 ) Clinical Importance of Bioavailable
Vitamin D: Development and analytical validation bioavailable 25 hydroxy
Vitamin D assay . Clinical chemistry 59 : S 112.
85. Attaelmannan M , Pandian R ,Thomassian K, Khachatryan S, Kumar A ( 2013 ) Development and validation of an improved chemiluminescent assay for Inhibin B . Clinical chemistry 59 : S 95.
86. Attaelmannan M , Pandian R ,Sadri M,Thomassian K, Khachatryan S, Kumar A ( 2013 )
Development of a broad-range sensitive and specific immunoassay for Anti-Mullerian Hormone(AMH) with no dilution issues. Clinical Chemistry 59 : S 95.
87. Pandian R, Pandian J,Seres, Z and Elias A ( 2014 ) Calcitriol and its free and
bioavailable fractions are better markers than 25 hydroxy vitamin D for monitoring
vitamin D status during Pregnancy. Clinical Chemistry Abstract # AACC meeting ,
07/14.
88 . Ross L, Jones T,Ingles S , Rudick , B , Pandian R et al ( 2014 ) Characterization
of bioavailable vitamin D status and its impact on IVF outcomes in non-hispanic whites
and Asian populations . Abstract for Amer Soc Reprod Medicine .
89. Pandian M.R. Pandian , J, Seres Z , Elias, A ( 2015) Bioavailable fractions are better
markers than 25 hydroxy vitamin D for monitoring vitamin D status during pregnancy . The endocrine Society 97 th Annual Meeting , San Diego , CA .Abstract # OR 45-3
90. Ross L , Jones T, Ingles S ,Pandian R et al ( 2015) Redefining the diagnosis of vitamin
D Deficiency in IVF patients.The endocrine Society 97 th Annual Meeing, San Diego,CA
Abstract # 238.
91. Pandian R, Goetzl EJ, Misuhashi M (2016) Plasma Neuron derived exosomal protein
biomarkers in the diagnosis of Alzheimer’s Disease. American Association of Clinical Chemistry annual meeting in Philadelphia . Abstract # 16-A-715.
Publications
PUBLICATIONS:

1. Pandian M.R. and Talwar G.P. (1971) Effect of growth hormone on the metabolism of thymus and on the immune response against sheep erythrocytes. J. Exp. Med. 134, 1905-1113.
2. Pandian M.R., Gupta S.L., and Talwar G.P. (1971) Studies on the early interactions of growth hormone. Effect in vitro and in vivo. Endocrinology 88, 928-933 on lipogenesis in adipose tissue.
3. Pandian, M.R. and Talwar, G.P. (1972) Influence of growth hormone thymus metabolism in vitro. Biochem J. 128, 57.

4. Talwar G.P., Gupta S.L., Pandian M.R., Sharma S.K., Rao K.N., Jailkhani B.L., Sen I.K., Sopori M.D., Basu A.K., and Jha P. (1972) Similarities and differences in the mode of action of growth hormone and estradiol. In hormones and development, (M. Hamburgh and E.J.W. Barrington, eds) Appleton Century Crofts, New York, pp. 95-100.
5. Talwar G.P., Jailkhani B.L., Sharma S.K., Sopori M.D., Pandian M.R., Sunharadas G., and Rao K.N. (1970) Mechanism of action of growth and estrogen. Ciba Found.
Symp. on "Control Processes in Multicellular Organism", (G.E.W. Wolstenholme and J. Knight, eds), J&A Churchill, London, pp. 23-27).
6. Pandian M.R., and Talwar G.P. (1974) Influence of pituitary growth hormone on immune response in rats. In Aspects of Allergy and Applied Immunology, Vol. IV (R.K. Sanyal, A. Arora and M. Dave, eds), Atmaram and Sons, New Delhi, India, pp. 23-27.
7. Talwar G.P., Jumar N., Pandian M.R., and Gupta R.D., (1974) Cellular and molecular correlates on the decline in responsiveness of cartilage and thymus to growth hormone in aged animals. Molec. Cell Endocrinol. 1, 209-226.
8. Pandian M.R. and Talwar G.P. (1974) Pituitary growth hormone and thymus. Proc. 5th Asia and Oceania Congress of Endocrinology (G.K. Rastogi, ed), Vol. II, pp. 266-275.
9. Pandian M.R., Gupta R.D., Talwar G.P., and Avrameas S. (1975) Proesence of "receptors" for growth hormone on membranes of thymocytes. Acta Endocrinol. 78, 781-790.
10. Bahl O.P., Pandian M.R., Moyle W.R., and Kobayashi Y. (1975) Chemistry of human chorionic gonadotropin and fertility regulation. In Advances in Fertility Regulation Through Basic Research (W.A. Sadler and S. Segal, eds), Plenum Press, New York.
11. Talwar G.P., Pandian M.R., Kumar N., Hanjan S.N.S., Saxena R.K., Krishna R.R., and Gupta S.L. (1975) Mechanism of action of pituitary growth hormone. Rec. Prog. Horm. Res. 31, 141-174.
12. Pandian M.R., Bahl O.P., and Segal S.J., (1975) Labeling of Lh/hCG receptor in rat ovaries. Biophys. Biochem. Res. Comm. 64, 1199-1205.
13. Bahl O.P., Pandian M.R., and Ghai R.D. (1976) Immunological properties of the B subunit of human chorionic gonadotropin. Biophys. Biochem. Res. Comm. 70, 525-532.
14. Pandian M.R. and Bahl O.P. (1977) Specific labeling of bovine corpus luteal plasma membrane hCG/LH receptor and its purification and properties. Arch. Biochem. Biophys, 182, 420-436.
15. Bahl O.P., Pandian M.R., and Lippes J. (1977) A highly specific and rapid radioimmunoassay for the determination of human chorionic gonadotropin. Proc. Internat. Symp. Fertility and Sterility, pp. 55-63.
16. Pandian M.R., Mitra R., and Bahl O.P. (1980). Immunological properties of the B subunit of human chorionic gonadotropin of the B subunit of human chorionic gonadotropin (hCG). II. Properties of an hCG specific antibody prepared against a chemical analog of the B subunit. Endocrinology 107, 1564-1571.
17. Ghai R.D., Mise T., Pandian M.R., and Bahl O.P. (1980) Immunological properties of the B subunit of human chorionic gonadotropin. I. Effect of chemical and enzymatic modifications. Endocrinology 107, 1556-1563.
18. Pandian M.R., Horvat A. and Said, S.I. (1982) Radioimmunoassay of VIP in blood and tissues. In Vasoactive Intestinal Polypeptide, (Said S.I., ed), Raven Press, New York, pp. 35-50.
19. Underwood L.E., Smith E.P., VanWyk J.J., Clemmons D.R., D'Ercole A.J., Pandian M.R., Preece M.A., and Moore W.V. (1986) Somatomedin C/Insulin Like Growth Factor I: Regulation and clinical applications in human growth hormone (Raiti S. and Toleman R. eds.) Plenum Press, New York, pp. 609-619.
20. Pandian M.R. (1986) Atrial Natriuretic Peptide. Clin. Chem. News, 12:14.
21. Elias A.N, Iyer K., Pandian M.R., Weatherbee P., Stone S., and Tobias J. (1986) The relationship between ?-endorphin and ?-lipotropin release and the basal and LRH
stimulated gonadotropin secretion after acute exercise in normal males. J. Applied Physiol. 61, pp. 2045-2049.
22. Elias A.N, Vaziri N.D., Pandian M.R., Iyer K. and Ansari M.A. (1987) Gamma-amino butyric acid and the dysregulation of TSH secretion in uremic male rats. Nephron 46 pp. 301-304.
23. Bogart M.H., Pandian M.R., and Jones O.W. (1987) Abnormal maternal serum chorionic gonadotrophin levels in pregnancies with fetal chromosomal abnormalities. Prenatal Diagnosis 1, pp. 623-630.
24. Elias A.N., Vaziri N.D., Pandian M.R., Iyer K., and Ansari M.A. (1987) Dopamine and TSH secretion in Uremic male rats. Hormone Res. 27: pp. 102-108.
25. Fisher D.A., Pandian M.R., and Carlton E. (1987) Autoimmune thyroid disease, an expanding spectrum. Ped. Clin. N. Amer. 34:907.
26. Elias A. N., Vaziri N.D., Pandian M.R., Powers D.R. and Domurat E. (1988) Atrial Natriuretic peptide and arginine vasopressin in pregnancy and pregnancy induced hypertension. Nephron 49: 143-149.
27. Elias A.N., Vaziri N.D., Pandian M.R., Domurat E., Ansari M.A., and Yagdani M. (1988) Atrial Natriuretic peptide, Arginine vasopressin, and the renin-angiotensin system in carbontetrachloride induce hepatitis in rats. Res. Commun. Chem: Path. Pharmacol. 60:401-404.
28. Elias A.N., Vaziri N.D., Pandian M.R., Iyer K. and Ansari M.A. (1988) Endogenous Opioids and TSH secretion in Azotemic male rates. Neuroendocrinology 47: 181-188.
29. Manoogian C., Pandian M.R., Ehrlich L., Fisher D., and Horton R. (1988) Plasma atrial natriuretic hormone levels in patients with the syndrome of inappropriate antidiuretic hormone secretion. J. Clin. Endorinol. Metabol. 67:571-757.
30. David R., Powers A.C., Pandian M.R., Godine J.E., and Axelrod L. (1989) Increased insulin like growth factor II Production and Consequent Suppression of Growth Hormone Secretion: A dual mechanism for tumor induced hypoglycemia. J. Clin. Endocrin. Metab. 68:701-706.
31. Elias A.N., Vaziri N.D., Pandian M.R., Iyer K., Ansari M.A., and Yazdani M. (1988) Gonadotropin Secretion in Azotemic male rats - effect of opioid blockade. Horm Res. 30:39-43.
32. O'Connor D.T., Pandian M.R., Carlton E., Cervenka J., and Hsiao R.J. (1989) Radioimmunoassay of circulating Chromogranin A: In Vitro Stability, exploration of the neuro endocrine character of neoplasia and assessment of the effects of organ failure. Clin. Chem. 35:1631-1637.
33. Elias A.N., Vaziri N.D., Pandian M.R., and Kaupke J. (1989) Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end stage renal disease. Int. J. Art. Organs 12:153-158.
34. Nageotte M.P., Hurwitz S.R., Kaupke C.J., Vaziri N.D., and Pandian M.R. (1989) Atriopeptin in the twin transfusion syndrome. Obstet. Gynec. 73:867-870.
35. Elias A.N., Fairshter R., Pandian M.R., Domurat E., and Kayaleh R. (1989)
?-Endorphin/?-lipotropin release and gonadotropin secretion after acute exercise in physically conditioned males. Eur. J. Appl. Physiol. 58:522-527.
36. Elias A.N., Ruokis Y., Pandian M.R., Domurat E., Gwinup G. (1989) Gut hormonal response to gluvose challenge in a patient with benign multiple symmetric lipomatosis. J. Obesity 8:41-51.
37. Nelson J.C., Linarelli L.G., and Pandian M.R. (1989) Discordant RIA Results for Thyroxin Binding Globulin (TBG): A New Indicator of Variant TBG Molecules With Decreased Affinity for Thyroxin. Clin. Chem. 35:1257-1258.
38. Andress D.L., Pandian M.R., Endres D.B., and Kopp J.B. (1989) Plasma Insulin Like Growth Factors and Bone Formation in Uremic Hyperparathyroidism
Kidney Intl. 36:471-477.
39. Takiyyuddin M.A., Cervenka J.H., Pandian M.R., Stuenkel C.A., Neumann H.P.H., and O'Connor D.T. (1990) Neuroendocrine Sources of Chromogranin A in Man: Clues From Selective Stimulation of Endocrine Glands Circulation J. Clin. Endocrin. Metabl. 71:360-369.
40. Pandian M.R., Morgan C., Nelson J.C., and Fisher D.A. (1990) A Method for Differentiating the Various Abnormalities of T4 Binding to Serum Proteins Using T4 Radioelectrophoresis and Binding Proteins Immunoassays. Clin. Chem. 36:457-461.
41. Elias A.N., Vaziri N.D., Pandian M.R., and Ansari M.A. (1989) Relationship Between ?-endorphin/?-lipotropin, Hyperglycemia, and Hyperinsulinemia In Obese Male Zucker Rats. Proc. Soc. Exp. Biol. Med. 192:157-160.
42. Friedman A.J., Rein M.S., Pandian M.R., and Barbieri R.L. (1990) Fasting Serum Growth Hormone and Insulin Like Growth Factor I and II Concentrations in Women with Leiomyomta Uteri Treated with Leuporlide Acetate or Placebo. Fert. Steril. 53:250-253.
43. Takiyyuddin M.A., Cervenka J.H., Patrick R.T., Sullivan A., Pandian M.R., Parmer R.J., Barbosa J.A., and O'Connor D.T. (1990) Is Physiologic Sympathoadrenal Catecholamine Release Exocytotic in Humans? Circulation 81:185-195.
44. Elias A.N., Vaziri N.D., Pandian M.R., Domurate E., and Ansari A. (1990) ANP, AVP, aldosterone and plasma renin activity in carbon tetra-chloride-induced cirrhosis in rats. J. Pharmacol. Exp. Ther. 252:438-441.
45. Elias A.N., Vaziri N.D., Pandian M.R., Nawabi M.A., Khamiseh G. (1990) Glucose intolerance in renal failure - Role of endogenous opioids. J. Lab. Clin. Med. 116:191-195.
46. Rein M.S., Freidman A.J., Pandian M.R., and Heffner L.J. (1990) The secretion of insulin like growth factors I and II of fibroids and myometrium from women treated with a gonadotropins-releasing hormone agonist: Obstet Gynalc. 76:1-7.
47. Elias A.N., Wilson A.F., Pandian M.R., Chune G., James N., Stone S.C. (1991) CRH and gonadotropin secretion in physically active males after acute exercise. Eur. J. Appl. Physiol 62:171-174.
48. Elias A.N., Domurat E., Pandian M.R., Fairshter R. Kayaleh R., and Chune G. (1991) Concentrations of volume regulatory hormones after acute exercise in physically conditioned males. J. Med. 22:55-67.
49. Pandian M.R., Morgan C., Carlton E., and Segre G.V. (1992) An immunoradiometric assay for parathyroid hormone - related protein and its clinical application in the differential diagnosis of hypercalcemia. Clinical Chemistry 38:282-288.
50. Elias A.N., Kayaleh R.A., Pandian M.R., Chune G. (1991) Inhibin and gonadotropin secretion after acute exercise in physically active males after exercise. Human Reproduction 6:747-750.
51. Elias A.N., Gordon I, Vaziri N.D., Pandian M.R., Chune G, Gwinup G, Wesley R. (1992) Effective portal insulin delivery with enzyme-protected capsules in pancreatectomized pigs. Gen. Pharmacol 23:55-59.
52. Bhasin S., Swerdloff R.S., Steiner B., Peterson M.A., Meridores T., Galmarini M., Pandian M.R., Goldberg R., Berman N. (1991) A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men. J. Clin. Endocr. Metab. 74:75-83.
53. Herpolsheimer A., Brady K., Yancey M.K., Pandian M.R., and Duff P. (1991) Pulmonary function of preeclamptic women receiving intravenous magnesium sulfate seizure prophylaxis. Obstet. Gynecol. 78:241-244.
54. Pandian M.R., and Fisher D.A. (1992) "Immunoradiometric assays" in Handbook of Endocrine Research Techniques (ed) Bruce Weintraub. Academic Press, San Diego, pp. 25-54.
55. Nelson J.C., Wilcox R.B., and Pandian M.R. (1992) Dependence of Free Thyroxine estimates obtained with equilibrium tracer dialysis on the concentration of thyroxine binding globulin. Clin. Chem. 38:1294-1300.
56. Bhasin S., Swerdloff R.S., Steiner B., Peterson M.A., Meridores T., Galmarini M., Pandian M.R., Goldberg R., and Berman N. (1992). A biodegradable testosterone microcapsul formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men. J. Clin. Endocrin. Metab., 74:75-83.
57. Pandian M.R. (1992) Nomeclature for TSH assays. Clin. Chem. News, September Issue, P. 15.
58. Elias A.N., Jacowatz J., and Pandian M.R. (1992) Parathyroid hormone-related protein in patients with malignant melanoma. Arch Dermatol 128:278-279.
59. Morgan T.R., Morgan K., Vaziri N.D., and Pandian M.R. (1992) Increased glomerular atrial natriuretic peptide receptor affinity in experimental nephrotic syndrome. Life Sciences 51:337-344.
60. Knorr K.L., Hilsenbeck S.G., Wenger C.R., Pounds G., Oldaker T., Vendely P., Pandian M.R., Harrington D., and Clark G.M. (1992) Marking the most of your prognostic factors: presenting a more accurate survival model for breast cancer patients. Breast Cancer Res and Treatment. 22:251-262.
61. Cesario T.C., Vaziri N.D., Ulrich T.R., Khamiseh G., Ovoisi F. Rahimzadeh M., Yousefi S., and Pandian M.R. (1992) Functional biochemical an histopathologic consequences of high dose interleukin-2 administration in rats. J. Lab Clin. Med. 118:8188.
62. Ravdin P.M., Clark G.M, Hilsenbeck S.G., Owens M.A., Vendely P., Pandian M.R., and McGuire W.L. (1992) A demonstration that breast cancer reoccurence can be predicted by neural network analysis. Breast Cancer Res. Treatment 21:47-53.
63. Elias A.N., Carreon G., Vaziri N.D., Pandian M.R. and Oveisi, F. (1992) The pituitary gonadal axis in experimental nephrotic syndrome in male rats. J. Lab Clin Med 120:949-954.
64. Elias A.N., Wilson A.F., Pandian M.R., Kayaleh R. (1992) Plasma chromogranin-A concentrations after acute exercise in male volunteers. Clin. Chem. 38:2348-2349.
65. Elias A.N., Wilson A.F., Pandian M.R., Rojas F.J. Kayaleh R. Stone S.C., and James N. (1993) Melatonin and gonadotropin secretion after acute exercise in physically active males. Eur. J. Appl. Physiology 66:357-361.
66. Clark G.M., Wenger C.R., Beardslee S., Owens M.A., Pounds G., Oldaker T., Vendely P., Pandian M.R., Harrington D., and McGuire W.L. (1993) How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regards to primary breast cancer. Cancer 71:2157-2162.
67. Clark GM, Wenger B.A., Beardslee S., Owens M.A., Pounds G., Oldaker T., Vendely P., Pandian MR, Harrington D., and McGuire W.L. (1993) How to integrate steroid hormone receptor, flow cytometric and other prognostic information in regard to primary breast cancer. Cancer 71:2157-2162.
68. Lipnick R.N., HungW., Pandian M.R. (1993) Neurosarcoidosis presenting a secondary amenorrhea in a teenager. J. Adolesc. Health 4:464-467.
69. Buena F., Swerdloff R.S., Steiner B.S., Lutchmansingh P., Peterson M.A., Pandian M.R., Galmarini M., Bhasin S. (1993) Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fert. Sterile 59:1118-1123
70. Johnson P.W., Joel S.P., Love S., Butcher M., Pandian M.R., Squires L., Wrigley P.F., Slevin M.L. (1993) Tumor markers for prediction of survival and monitoring of remission in small cell lung cancer. Br J Cancer. 67:760-766.
71. Pandian M.R., Odell W.D., Carlton E., Fisher D.A. (1993) Development of third generation immunochemiluminometric assays for follitropin and lutropin and their clinical application in determining pediatric reference ranges. Clin. Chem. 39:1815-1819.
72. Wenger C.R., Beardslee S., Owens M.A., Pounds G., Oldaker T., Vendely P., Pandian M.R., Harrington D., Clark G.M., and McGuire W.L. (1993) DNA ploidy, S-phase and steroid receptors in more than 127,000 breast cancer patients. Breast Canc. Res. Treat., 28:9-20.
73. Finegold D.N., Armitage M.M., Galiani M., Matise T.C., Pandian M.R., Perry Y.M., Deka R., and Ferrell R.E. (1994) Assignment of a gene for autosomal dominant hypoparathyroidism to chrosomosome 3Q13. Ped. Res. 36:414-417.
74. Vaziri N.D., Pandian M.R., Segal J.L., Winer R.L., Eltorai I., and Brunnemann S. (1994) Vitamin D, parathormone and calcitonin profiles in patients with long standing spinal cord injury. Arch. Phys. Med. Rehab. 75:766-769.
75. Pandian M.R. (1994) Is PSA the dream child of the decade for prostate cancer. "News and Views" published by National Acad. Clin. Biochemistry, July, 1994
pp 1-4.
76. Wagner S.L., Peskind E.R., Nochlin D., Provow S., Farrow J.S., Pandian M.R., Cleveland M., Ito R., Farlow M.R. (1994) Decreased levels of soluble amyloid beta protein procursor are associated with Alzheimer's disease in concordant and discordant monozygous twin pairs. Annals of Neurology 36:214-220.
77. Elias A.N., Pandian M.R. (1994) Diagnosis of Hyperaldosteronism in a Patient with Persistent Hypokalemia. American Association of Clinical Chemistry - In Service Training ENDO, 12:151-155, June 1994.
78. Elias A.N., Pandian M.R. (1995) Prorenin and IGF-I in Diabetic Retinopathy. American Association of Clinical Chemistry - In Service Training ENDO, 13:39-42, 1994.
79. Elias A.N., Stone S.C., Tayyanipour R., Pandian M.R., Rohas FJ, Swinup G. (1995) Relationship between serum estradiol concentration and IGF-I, IGF-II, and IGF-binding proteins in patients with premature ovarian failure on short-term estradiol therapy. Int J Fertil 40:196-201.
80. Elias A.N., Pandian M.R., Naqvi F., Sebag J., Charles M.A., Gwinup G. (1996) Relationship betwen prorenin, IGF-I, IGF-binding proteins, and retinopathy in diabetic patients. Gen Pharmacol 27:329-332.
81. Peskins E.R., Leverenz J., Farlow M.R., Ito R.K., Provow S.A., Siegel R.D., Cleveland M., Morgan C.H., Pandian M.R., Corbin S., Nochlin D., Schellenberg G.D., Raskind
M.A., Wagner S.L. Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls. (1997) Alzheimer Dis Assoc Disord. 11:201-206.
82. Elias A.N., Wesley R.C., Gordon I.L., Pandian M.R., Vaziri N.D. (1997) Effects of adenosine on renal function, plasma ANP an ADH concentrations, and central hemodynamics in anesthetized pigs. Gen Pharmacol 28:429-433.
83. Elias A.N., Pandian M.R., Rojas F.J. (1997) Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure to age-matched menstruating controls. Gynecologic and Obstetric Investigation 43:47-48.
84. Elias A.N., Wilson A.F., Pandian M.R., Naqvi S. (1997) Effects of blood pH and blood lactate on growth hormone, prolactin and gonadotropin release after acute exercise in male volunteers. Proc Soc Exp Biol & Med 214:156-160.
85. Elias A.N., Gordon I.L., Porzio R., Willia L., Pandian M.R., Gwinup G.(1997) Intracecally administered insulin in chronically diabetic pigs. Current Therapeutic Research 58: 16-25.
86. Saxe A., Dean S., Gibson G., Pandian M.R., and Levy J. (1997) Parathyroid hormone and parathyroid hormone related peptide in venous umbilical cord blood of healthy neonates. J. Ped. Med. 25:288-291.
87. Burman K.D., Pandian M.R. (1998) Clinical utility of assays of TSH receptor antibodies. The Endocrinologist 8:284-290.
88. Gruber H.E., Ding Y., Stasky A.A., Meyer M., Pandian M.R., Pandian D., Vaziri N.D., Grigsby J., Gonick H.C. Adequate dietary calcium mitigates osteopenia induced by chronic lead exposure in adult rats. (1999) Miner Electrolyte Metab. 25:143-6.
89. Elias A.N., Pandian M.R., Wang L., Suarez E., James N., Wilson A.F. Leptin and IgF-I levels in unconditioned male volunteers after short-term exercise. (2000) Psychoneuroendocrinology. 25:453-61.
90. Vaziri N.D., Ni Z., Oveisi F., Liang K. and Pandian M.R. (2002) Enhanced Nitric Oxide Inactivation and protein Nitration by reactive Oxygen species in Renal insufficiency. Hypertension 39:135-41.
91. Kantorovich V., Adams J.S., Gaines J.E., Guo X., Pandian M.R., Cohn D.H. and Rude R.K. (2002) Genetic heterogeneity in familial renal magnesium wasting. J. Clin. End. Metab. 87:612-7.
92. Pandian R., Lu J., and Ossolinska-Plewnia J. (2003). Fully automated chemiluminometric assay for hyperglycosylated human chorionic gonadotropin (Invasive trophoblast antigen). Clin. Chem. 49:808-10.
93. Pandian R., and Nakamoto, J.M. (2003) Rational use of the laboratory for childhood and adult growth hormone deficiency in “Hot topics in Endocrinology” clinics in Laboratory Medicine, Winter W.E. (ed). Saunders Pubs, pp. 141-174.
94. Palomaki GE, Knight GJ, Robertson MM, Cunningham GC, Lee JE, Strom CM, Pandian R (2004) Second trimester maternal urine invasive trophoblast antigen (ITA, hyperglycosylated hCG) as a marker for Down syndrome: Preliminary results of an observational study on fresh samples. Clin. Chem 50:182-9.
95. Elias AE, Nanda VS, and Pandian R (2004) Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene. Dermatology 4:4-8.
96. Weinans MJN, Sancken U, Pandian R, Ouweland JMW, de Bruijn HWA, Holm JP, and Mantingh A (2004) Invasive trophoblast antigen (hyperglycosylated hCG) as a first trimester serum marker for Down’s syndrome. In “ Operationalization of first trimester maternal serum screening for Downs syndrome “ ed MJN Weinans .Publishers Ponsen & Looyen BV , Wageningen .PP 111-122.
97. Pandian R, Cole LA, and Palomaki G. (2004) Second trimester maternal serum invasive trophoblast antigen (ITA): a marker for Down syndrome screening. Clin Chem 50:1433-35.
98. Weinans MJN, Sacken U, Pandian R, Ouweland JMW, deBruijn HWA, Holm JP, and Mantingh A (2005) Invasive trophoblast antigen (hyperglycosylated hCG) as a first trimester serum marker for Down syndrome. Clin Chem 51 : 1276 – 1279.
99. Palomaki GE, Neveux LM, Knight GJ, Haddow JE, and Pandian R (2004) Maternal serum invasive trophoblast antigen (ITA) as a screening marker for Down syndrome during the second trimester. Clin Chem 50 (10): 1804-1808.
100. Palomaki GE , Knight GJ , Neveux LM , Pandian R , Haddow JE ( 2005 ) Maternal serum Invasive Trophoblast antigen and First Trimester Down Syndrome Screening .
Clin Chem 51 : 1499 – 1504.
101. Vaziri ND , Bai Z, Ni Y , Quiroz Y, Pandian R , and Rodriguez-Iturbe B ( 2007 ) Intra-renal Angiotensin II / AT1 Receptor , oxidative stress , inflammation , and progressive injury in Renal Mass Reduction . J Pharmacology and Experimental Therapeutics 323: 85 – 93 .
102. Strom CM, Bonilla-Guererro R, Zhang K, Doody KJ, Tourgeman D, Alvero R, Cedars MI, Crossley B, Pandian R, Sharma R, Neidich J, Salazar D(2012) The sensitivity and specificity of hyperglycosylated hCG (hhCG) levels to reliably diagnose clinical IVF pregnancies at 6 days following embryo transfer.J Assist Reprod Genet. 29(7):609-614.
103. Yingchun Li, Matteo Moretto-Zita, Francesca Soncin, Anna Wakeland, Lynlee Wolfe,
Sandra Leon- Garcia, Raj Pandian, Donald Pizzo, Li Cui, Kristopher Nazor,
Jeanne F. Loring,Christopher P. Crum, Louise C.Laurent, and Mana Parast (2013)
BMP4-directed trophoblast differentiation of human embryonic stem cells is mediated
through a#916;Np63+ cytotrophoblast stem cell state . Development 140:3966-76.
104. Chuan S,Homer M, Pandian R, Conway D, Garzo G, Yeo , L Su I ( 2014)
Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy
outcomes after in vitro fertilization .Fertility Sterility 101 : 392 -398.
105. Ross L, Ingles SA, Pandian R, Stanczyk F, Jones T, Rudick B, Paulson R, Bendikson
(2016) Redefining the Diagnosis of Vitamin D Deficiency in IVF Patients. Human
Reproduction (submitted)
Professional Societies
American Association of Clinical Chemistry
American Society for Endocrinology
National Academy of Clinical Biochemistry
Other Experience
Director of Laboratories
Nichols Institute 1979—1988

Senior Laboratory Director
Senior Laboratory Director 1988—2012

Director of Scientific Affairs
Pan Laboratories 2013—Pres

Graduate Programs
Cell Biology

Research Center
Pan Laboratories
Last updated
10/20/2016